Today about 33 million people worldwide are living with atrial fibrillation or AFib, the most common heart rhythm disorder. That number is expected to increase by up to 70% by 20301. That’s concerning because patients with AFib are more likely to have a stroke and at higher risk for other potentially devastating complications.
To address the demands of this rising epidemic, the Johnson & Johnson Institute and Biosense Webster welcomed more than 900 members of the Electrophysiologist (EP) community to the AFib symposium in Copenhagen. Over three days, an esteemed international faculty presented an agenda reflecting the newest developments, research and perspectives in AFib diagnosis and treatment.
“It’s an honor to bring together the AF community to discuss and debate the newest developments and research to advance AF treatment towards the goal of healing more hearts,” said Prof D. Shah (Switzerland) Scientific Committee Member.
Education to Improve Procedure Workflow, Patient Care
The Symposia practical sessions focused on all aspects of the AFib ablation procedure and the practical usage of new technologies in the field of AFib ablation. The scientific session included high-level lectures that were case-based and geared towards improving procedure workflow and, ultimately, patient care.
“AFib is a significant health issue that is placing a growing burden on patients, caregivers and healthcare systems, particularly in Europe,” said Meret Labhart, Professional Education Leader, EMEA. “The Johnson & Johnson Institute is committed to delivering innovative education and training to help healthcare providers meet the challenges of this new millennium epidemic.”
Improving Earlier Diagnosis of AFib
Up to 30 percent of AFib patients experience no symptoms which may contribute to a delayed diagnosis which subsequently can result in life-threatening complications, signaling a critical need for more efficient and scalable screening methods. To meet this need,Johnson & Johnson announced a research study with Apple Watch to help improve Afib outcomes, including stroke prevention. Click here to learn more